Summit Therapeutics (SMMT) Stock Jumps As Market Embraces New Lung Cancer Data
Fahim Awan
September 9, 2024
The shares of Summit Therapeutics Inc. (NASDAQ: SMMT) surged 62.84% to $19.98 today in reaction to positive findings from a Phase III clinical trial. During